CORRESP Filing
Aspira Women's Health Inc.
Date: Nov. 19, 2025 · CIK: 0000926617 · Accession: 0001104659-25-114080
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290633
Letter
November 19, 2025 VIA EDGAR TRANSMISSION U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attention: Daniel Crawford Re: Aspira Women’s Health Inc. Registration Statement on Form S-1 Filed October 20, 2025 (File No. 333-290633) Dear Mr. Crawford, In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request the acceleration of the effective date of the above-referenced Registration Statement, so that it will become effective on November 21, 2025, at 4:00 p.m., Eastern Time, or as soon as thereafter as practicable, or at such later time as Aspira Women’s Health Inc. (the “ Company ”) or its counsel may request via telephone call to the Staff. Please contact J. Eric Johnson of Winston & Strawn LLP, counsel to the Company, at (713) 651-2647 to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter. Sincerely yours, Aspira Women’s Health Inc. By: /s/ Mike Buhle Name: Mike Buhle Title: Chief Executive Officer cc: J. Eric Johnson, Esq.
Show Raw Text
CORRESP 1 filename1.htm November 19, 2025 VIA EDGAR TRANSMISSION U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attention: Daniel Crawford Re: Aspira Women’s Health Inc. Registration Statement on Form S-1 Filed October 20, 2025 (File No. 333-290633) Dear Mr. Crawford, In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request the acceleration of the effective date of the above-referenced Registration Statement, so that it will become effective on November 21, 2025, at 4:00 p.m., Eastern Time, or as soon as thereafter as practicable, or at such later time as Aspira Women’s Health Inc. (the “ Company ”) or its counsel may request via telephone call to the Staff. Please contact J. Eric Johnson of Winston & Strawn LLP, counsel to the Company, at (713) 651-2647 to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter. Sincerely yours, Aspira Women’s Health Inc. By: /s/ Mike Buhle Name: Mike Buhle Title: Chief Executive Officer cc: J. Eric Johnson, Esq.